News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Nivolumab bests ipilimumab in head-to-head melanoma trial
28 Oct 2025
byAudrey Abella
The final, long-term results from the phase III CheckMate 238 trial continue to show the superior recurrence-free survival (RFS) benefit of adjuvant nivolumab (NIVO) over ipilimumab (IPI) for resected stage IIIB-C or IV melanoma.
28 Oct 2025

HK data: LAI antipsychotics superior to oral antipsychotics in older patients with schizophrenia
28 Oct 2025
byKanas Chan
Long-acting injectable (LAI) antipsychotics are associated with lower risks of disease relapse and mortality than oral antipsychotics in older patients with schizophrenia, a population-based study in Hong Kong has shown.
28 Oct 2025






